Drug Type Small molecule drug |
Synonyms Simenepag (USAN/INN), Simenepag Isopropyl |
Target |
Action agonists |
Mechanism EP2 agonists(Prostanoid EP2 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseClinical |
First Approval Date- |
Regulation- |
Molecular FormulaC23H29NO5S |
InChIKeyNGKFLYGSJDSBQC-QUCCMNQESA-N |
CAS Registry910562-15-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D09962 | - | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glaucoma | Phase 2 | United States | 04 Nov 2010 |